✦ LIBER ✦

Pharmacoeconomic aspects of adjuvant early breast cancer treatment in postmenopausal women with anastrozole or tamoxifen: a Slovenian perspective

✍ Scribed by P Piskur; M Sonc; T Cufer; S Borstnar; A Mrhar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost utility analysis of early adjuvant

✍ Jonathan Karnon; Thomas Delea; Vicki Barghout 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 297 KB

Pharmacoeconomic analysis of adjuvant th

✍ Juan Miguel Gil; Carlos Rubio-Terrés; Almudena del Castillo; Paloma González; Fe 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 827 KB

‘Arimidex’ (anastrozole) versus tamoxife

✍ Aman U. Buzdar 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Cost-effectiveness of anastrozole vs tam

✍ R.E Mansel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 525 KB

Anastrozole alone or in combination with

📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 150 KB

Effectiveness of switching from adjuvant

✍ Walter Jonat; Michael Gnant; Francesco Boccardo; Manfred Kaufmann; Alessandra Ru 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 101 KB